Case Report of COVID-19 and Pneumocystis coinfection in a pediatric patient with a history of receiving high dose steroid therapy

  • Sun Oh Yum
  • , Hwanhee Park
  • , Esther Park*
  • *Corresponding author for this work

Research output: Contribution to journalJournal articlepeer-review

Abstract

We report the first case of a critically ill pediatric patient coinfected with coronavirus disease 2019 (COVID-19) and Pneumocystis jirovecii pneumonia (PCP). Instances of coinfection of COVID-19 and PCP are being increasingly reported as the COVID-19 pandemic continues. Because the combination can be life-threatening, timely diagnosis and treatment for PCP is necessary in cases where an immunocompromised patient contracts COVID-19.

Original languageEnglish
Article numbere23477
JournalHeliyon
Volume10
Issue number1
DOIs
StatePublished - 2024.01.15

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Coinfection
  • Coronaviurs disease 2019 (COVID-19)
  • Corticosteroids
  • Immunocompromised children
  • Pneumocystis jirovecii pneumonia (PCP)
  • SARS-CoV-2

Fingerprint

Dive into the research topics of 'Case Report of COVID-19 and Pneumocystis coinfection in a pediatric patient with a history of receiving high dose steroid therapy'. Together they form a unique fingerprint.

Cite this